Write a reviewFor vendors
♡
Home / Investors / Kimbell Duncan

Kimbell Duncan

Angel Investor · London

About Kimbell Duncan

Angel investor (Chief Executive Officer) based in London, United Kingdom. Focus areas include Drug Discovery. Invests at early stage venture stage. Past investments include Curemark.

Investment focus

Stages
Early Stage Venture
Sectors
Drug Discovery

Portfolio

No portfolio companies recorded yet; Kimbell Duncan reports 1 investments overall.

Similar investors

Alexis Frentz

Venture Fund · Paris
SeedEarly Stage VentureAdvertisingHealth CareCommercialDrug Discovery+16
60Investments
—Exits

Anna Chen

Venture Fund · San Diego
Early Stage VentureLate Stage VentureHealth CareRegenerative MedicineDrug DiscoveryWellness+16
60Investments
—Exits

Anne-Sophie CARRESE

Venture Fund · Paris
SeedEarly Stage VentureAdvertisingHealth CareCommercialDrug Discovery+16
60Investments
—Exits

Annie Mitsak

Venture Fund · Boston
SeedEarly Stage VentureHealth CareDrug DiscoveryGeneticsAutoimmune Diseases+16
60Investments
—Exits

Anthony Wiemelt

Accelerator · Philadelphia
SeedEarly Stage VentureHealth CareResearch and DevelopmentRegenerative MedicineHospitals+16
60Investments
—Exits

Avak Kahvejian

Venture Fund · Cambridge
Early Stage VentureSeries ACreative VentureClean TechHealth CareResearch and Development+16
60Investments
—Exits